Serum CA19‐9, CA‐125 and CEA as tumor markers for mucinous ovarian tumors

Abstract AIM: To analyze the use of serum cancer antigen 19‐9 (CA19‐9), cancer antigen 125 (CA‐125) and carcinoembryogenic antigen (CEA) in predicting the malignant potential of mucinous ovarian tumor, and to assess the clinical factors associated with these tumors. METHODS: This retrospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Lertkhachonsuk, Arb‐aroon, Buranawongtrakoon, Supree, Lekskul, Navamol, Rermluk, Naparat, Wee‐Stekly, Wei‐Wei, Charakorn, Chuenkamon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693209/
https://www.ncbi.nlm.nih.gov/pubmed/32830422
http://dx.doi.org/10.1111/jog.14427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693209/
https://www.ncbi.nlm.nih.gov/pubmed/32830422
http://dx.doi.org/10.1111/jog.14427

Ejemplares similares